Skip to main content

Measurements of free hemoglobin and hemolysis index: EDTA- or lithium-heparinate plasma?

Unger J, Filippi G, Patsch W

Publication: Clin Chem (2007) • Vol 53 • Page 1717-8PMID: 17712012View on PubMed

Purpose

The purpose of this paper was to determine whether EDTA or lithium heparinate is the preferable anticoagulant for measuring free hemoglobin (fHb) and hemolysis index (HI) in plasma.

Conclusion

No significant differences in fHb or HI were observed between the two anticoagulants when they were used at usual concentrations (1.6 g EDTA/L of whole blood or 16 kIE lithium heparinate/L of whole blood). However, when EDTA was used at 3 times the normal concentration, as occurs when collection tubes are not adequately filled, fHb and HI were over 50% higher than when EDTA was used at standard concentrations. On the other hand, tripling lithium heparinate concentration did not affect fBh or HI.

Studies (1)

Purpose

The purpose of this study was to determine whether EDTA or lithium heparinate is the preferable anticoagulant for measuring fHb and HI in plasma.

Summary of Findings

No significant differences in fHb or HI were observed between the two anticoagulants when they were used at usual concentrations (1.6 g EDTA/L of whole blood or 16 kIE lithium heparinate/L of whole blood). However, when EDTA was used at 3 times the normal concentration, as occurs when collection tubes are not adequately filled, fHb and HI were over 50% higher than when EDTA was used at standard concentrations. On the other hand, increasing lithium heparinate concentration did not affect fBh or HI.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
    Not specified
  • Platforms

    ProteinSpectrophotometry
    Cell count/volumeHematology/ auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnticoagulant
    EDTA
    Lithium heparin